Search results
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 days agoAbbVie’s top line is being driven by sales of new immunology drugs, Skyrizi and Rinvoq. The Zacks...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 18 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 19 hours agoThe Zacks Consensus Estimate is pegged at $2.26 per share. AbbVie’s top line is expected to have...
AbbVie (ABBV) to Release Quarterly Earnings on Friday
ETF DAILY NEWS· 6 hours agoAbbVie (NYSE:ABBV – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, April 26th. Analysts expect the company to announce earnings of ...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks· 2 days agoFree Report) will announce quarterly earnings of $2.26 per share in its forthcoming report, representing a decline of 8.1% year over year. Ahead of a company's earnings disclosure, it is crucial ...
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s...
Fortune via Yahoo Finance· 2 days ago“We believe that growth from ABBV’s ex-Humira business (primarily Skyrizi, Rinvoq, and aesthetics)...
Artisan International Fund Q1 2024 Commentary
Seeking Alpha· 18 hours agoArtisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated...
Big pharma: cautious optimism ahead of earnings season - analysts
Proactive Investors· 7 days agoLooking ahead to the pharmaceutical earnings season, UBS expressed cautious optimism when looking at...
AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors on Wednesday, April 17th. William ...
AbbVie (NYSE:ABBV) Shares Up 1.8%
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 1.8% on Thursday . The company traded as high as $167.44 and last traded at $167.14. BMO Capital Markets raised their price target on shares ...